S SOTERA HEALTH CO
| Market Cap | $4.25B |
| P/E Ratio | 55.41 |
| Forward P/E | 14.29 |
| Dividend Yield | — |
| Beta | 1.88 |
| 52W Range | $9.80 - $19.35 |
| # Hedge Funds | 3 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| David Einhorn DME Capital Management | 0.29% | $8.14M | 461,270 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 9 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| WARBURG PINCUS & CO. | Sale | 15,000,000 | $15.27 | $229.05M | 06 Mar 2026 | 06 Mar 2026 |
| GTCR INVESTMENT XI LLC | Sale | 10,000,000 | $15.27 | $152.70M | 06 Mar 2026 | 06 Mar 2026 |
| Petras Michael B. Jr.Chairman & CEO | Sale | 315,896 | $16.45 | $5.20M | 08 Dec 2025 | 10 Dec 2025 |
| Petras Michael B. Jr.Chairman & CEO | Sale | 39,243 | $16.45 | $645.55K | 08 Dec 2025 | 10 Dec 2025 |
| Petras Michael B. Jr.Chairman & CEO | Sale | 394,861 | $16.45 | $6.50M | 08 Dec 2025 | 10 Dec 2025 |
| WARBURG PINCUS & CO. | Sale | 9,720,000 | $16.33 | $158.73M | 03 Dec 2025 | 05 Dec 2025 |
| GTCR INVESTMENT XI LLC | Sale | 6,480,000 | $16.33 | $105.82M | 03 Dec 2025 | 05 Dec 2025 |
| WARBURG PINCUS & CO. | Sale | 18,000,000 | $15.65 | $281.72M | 10 Nov 2025 | 12 Nov 2025 |
| GTCR INVESTMENT XI LLC | Sale | 12,000,000 | $15.65 | $187.81M | 10 Nov 2025 | 12 Nov 2025 |
Frequently Asked Questions
What is SHC stock price today?
SOTERA HEALTH CO (SHC) is currently trading at $14.96. The stock has a 52-week range of $9.80 to $19.35 and a market capitalization of $4.25B.
Is SHC a good stock to buy in 2026?
SOTERA HEALTH CO has a P/E ratio of 55.4 (forward P/E: 14.3), a dividend yield of none, and 1-year performance of +39.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling SHC stock?
There have been 9 insider transactions for SHC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has SHC stock performed over the past year?
SOTERA HEALTH CO (SHC) has returned +39.4% over the past 12 months. The stock traded between $9.80 and $19.35 during this period, and is currently at $14.96.
Which hedge funds own SHC (SOTERA HEALTH CO)?
1 tracked hedge funds currently hold SHC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is SHC's market cap and valuation?
SOTERA HEALTH CO (SHC) has a market capitalization of $4.25B. The trailing P/E ratio is 55.4 and forward P/E is 14.3. The stock is classified in the Healthcare sector.
What is SHC's revenue and profitability?
SOTERA HEALTH CO reported revenue of $1.16B with net income of $77.94M and a profit margin of 0.07%. The stock has a beta of 1.88.
What sector is SHC in and who are its biggest institutional holders?
SOTERA HEALTH CO (SHC) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.